Research and data on potential treatment modalities continue to emerge at a rapid pace. This episode explores the IDSA and NIH guidelines for the treatment and management of COVID-19, as well as available evidence on antivirals, glucocorticoids and antibodies.

• Intro :08
• Recap on spectrum of disease 1:53
• Treatment goals: 3 broad approaches 4:07
• Disease pathogenesis 5:45
• Remdesivir 7:58
• Dexamethasone 17:18
• Convalescent plasma 34:26
• Words from JFK 40:20

We’d love to hear from you! Send your comments/questions to Dr. Pai at [email protected]. Be sure to check Healio.com/coronavirus for daily updates on the pandemic and follow us on Twitter @InfectDisNews and @GoHealio.

Disclosures: Pai reports serving on the advisory boards of Abbvie and Gilead Sciences.